Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cefodizime Disodium
2. Cefodizime, Dipotassium Salt, (6r-(6alpha,7beta(z)))-isomer
3. Cefodizime, Disodium Salt, (6r-(6alpha,7beta(z)))-isomer
4. Hr 221
5. Hr-221
6. Modivid
1. 69739-16-8
2. Cefodizima
3. Cefodizimum
4. Cdzm
5. Cefodizime Disodium
6. Hr 221
7. Hr-221
8. Chebi:63214
9. Hr 221 [as Sodium]
10. Thr 221 [as Sodium]
11. Z31298j4hq
12. Cefodizime (inn)
13. (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
14. Modivid
15. S 77 1221 B [as Sodium]
16. Thr-221
17. Cefodizime [inn]
18. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,7-[[(2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-, (6r,7r)-
19. 7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
20. Cefodizime Sodium [jan]
21. Cefodizime Acid
22. Thr 221
23. (6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(((5-(carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid 7(sup 2)-(z)-(o-methyloxime)
24. Cefodizime [inn:ban]
25. Cefodizimum [inn-latin]
26. Cefodizima [inn-spanish]
27. S 77-1221b
28. S-77-1221b
29. S-77-1221-b
30. Cefodizme
31. Diezime
32. Timecef
33. Neucef
34. Unii-z31298j4hq
35. Cef;cdz
36. Cefodizime [mi]
37. Ec 700-301-3
38. Hr-221 [as Sodium]
39. Cefodizime [who-dd]
40. Thr-221 [as Sodium]
41. Hr 221 Free Acid
42. Hr-221 Free Acid
43. Thr 221 Free Acid
44. Thr-221 Free Acid
45. Schembl151101
46. Chembl2303613
47. Dtxsid2022757
48. S-771221b [as Sodium]
49. Ex-a1379
50. Zinc3871933
51. A0c261
52. Bdbm50422690
53. Mfcd00864926
54. S5235
55. S 77 1221 B Free Acid
56. S-77-1221-b Free Acid
57. Db13470
58. (6r,7r)-7-(((2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl)amino)-3-(((5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl)sulfanyl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
59. Hy-108402
60. Cs-0028575
61. D07643
62. J-700161
63. (6r,7r)-3-({[5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]sulfanyl}methyl)-7-{[(2z)-1-hydroxy-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)-2-(methoxyimino)ethylidene]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
64. (6r,7r)-7-({(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-({[5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]thio}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
65. (6r,7r)-7-{[(22z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-({[5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]sulfanyl}methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
66. 7-{[(22z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-({[5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]sulfanyl}methyl)-3,4-didehydrocepham-4-carboxylic Acid
| Molecular Weight | 584.7 g/mol |
|---|---|
| Molecular Formula | C20H20N6O7S4 |
| XLogP3 | 0.2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 10 |
| Exact Mass | 584.02763169 g/mol |
| Monoisotopic Mass | 584.02763169 g/mol |
| Topological Polar Surface Area | 305 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 1030 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DD - Third-generation cephalosporins
J01DD09 - Cefodizime
Global Sales Information
ABOUT THIS PAGE
12
PharmaCompass offers a list of Cefodizima API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefodizima manufacturer or Cefodizima supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefodizima manufacturer or Cefodizima supplier.
PharmaCompass also assists you with knowing the Cefodizima API Price utilized in the formulation of products. Cefodizima API Price is not always fixed or binding as the Cefodizima Price is obtained through a variety of data sources. The Cefodizima Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cefodizima manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefodizima, including repackagers and relabelers. The FDA regulates Cefodizima manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefodizima API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cefodizima supplier is an individual or a company that provides Cefodizima active pharmaceutical ingredient (API) or Cefodizima finished formulations upon request. The Cefodizima suppliers may include Cefodizima API manufacturers, exporters, distributors and traders.
Cefodizima Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefodizima GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefodizima GMP manufacturer or Cefodizima GMP API supplier for your needs.
A Cefodizima CoA (Certificate of Analysis) is a formal document that attests to Cefodizima's compliance with Cefodizima specifications and serves as a tool for batch-level quality control.
Cefodizima CoA mostly includes findings from lab analyses of a specific batch. For each Cefodizima CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefodizima may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefodizima EP), Cefodizima JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefodizima USP).
